Literature DB >> 29931542

Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases.

Satomi Kasashima1,2,3, Atsuhiro Kawashima4,5, Fuminori Kasashima6, Masamitsu Endo6, Yasushi Matsumoto6, Kengo Kawakami6.   

Abstract

Immunoglobulin (IgG) 4-related diseases (IgG4-RDs) are fibro-inflammatory conditions characterized by tumorous swelling and serum IgG4 levels. Intrapelvic IgG4-RD has been subclassified according to the localization site and aortic shape as IgG4-related aortic aneurysms (IgG4-AAs), periaortitis (IgG4-PA), and retroperitoneal fibrosis (IgG4-RF). The IgG4-AA pathogenesis would involve interleukin (IL)-6 upregulation, and Th2-predominant and Treg-activated immune conditions. We characterized the features of intrapelvic IgG4-RD lesions, including presence of vascular lesions. The clinical, serological, and pathological features, including cytokines concerning Th1/2 and Treg (IL-4, IL-6, IL-10, IL-13, and interferon-gamma) of patients with IgG4-AAs (n = 24), IgG4-PA (n = 8), and IgG4-RF (n = 10) were retrospectively compared. Clinical symptoms, such as low-grade fever, abdominal/lumber pain, and anemia, were frequently detected in IgG4-AAs but rarely in IgG4-RF. Serum IL-6 and C-reactive protein (CRP) were significantly higher in IgG4-AAs and IgG4-PA than in IgG4-RF. Pathologically, IL-6+ cells were more frequently detected in IgG4-PA and IgG4-AAs than in IgG4-RF. There were no noteworthy differences in the clinical complications, white blood cell counts, serum IgE, and serum and immunopositive cells of other cytokines between the subgroups. Among IgG4-AAs and IgG4-PA, serum IL-6 and IL-6+ cells correlated with CRP, aortic diameter, and periaortic fibrosis. IgG4-AA and IgG4-PA, but not IgG4-RF, were characterized by "inflammatory" features, such as increased CRP and serum/pathological IL-6, and clinical inflammatory symptoms; thus, IgG4-AA and IgG4-PA belong to the same group as IgG4-related vascular disease. High levels of CRP and IL-6 would be hallmarks of IgG4-related vascular disease.

Entities:  

Keywords:  Cytokine valance; IgG4-related aortic aneurysm; IgG4-related periaortitis; IgG4-related retroperitoneal fibrosis; Inflammatory abdominal aortic aneurysm; Inflammatory symptoms; Interleukins

Mesh:

Substances:

Year:  2018        PMID: 29931542     DOI: 10.1007/s00380-018-1203-8

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  45 in total

1.  Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process.

Authors:  J K ORMOND
Journal:  J Urol       Date:  1948-06       Impact factor: 7.450

2.  IgG4-related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis?

Authors:  Thomas Castelein; Walter Coudyzer; Daniel Blockmans
Journal:  Rheumatology (Oxford)       Date:  2015-01-12       Impact factor: 7.580

3.  Demonstration of immunoglobulin in the neighbourhood of advanced atherosclerotic plaques.

Authors:  D Parums; M J Mitchinson
Journal:  Atherosclerosis       Date:  1981 Jan-Feb       Impact factor: 5.162

4.  Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4.

Authors:  Yoh Zen; Manabu Onodera; Dai Inoue; Azusa Kitao; Osamu Matsui; Takahiro Nohara; Mikio Namiki; Satomi Kasashima; Atsuhiro Kawashima; Yasushi Matsumoto; Kazuyoshi Katayanagi; Tetsuya Murata; Shin Ishizawa; Noriko Hosaka; Ken Kuriki; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

5.  IgG4-related Disease Involving Multiple Organs with Elevated Serum Interleukin-6 Levels.

Authors:  Tsukasa Ikeura; Shunsuke Horitani; Masataka Masuda; Takeshi Kasai; Masato Yanagawa; Hideaki Miyoshi; Kazushige Uchida; Makoto Takaoka; Chika Miyasaka; Yoshiko Uemura; Kazuichi Okazaki
Journal:  Intern Med       Date:  2016-09-15       Impact factor: 1.271

6.  Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis.

Authors:  Stephanie Schulte; Galina K Sukhova; Peter Libby
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

7.  Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells.

Authors:  T B Sneed; D J Stanley; L A Young; R D Sanderson
Journal:  Cell Immunol       Date:  1994-02       Impact factor: 4.868

Review 8.  Retroperitoneal fibrosis - the state-of-the-art.

Authors:  Marta Runowska; Dominik Majewski; Mariusz Puszczewicz
Journal:  Reumatologia       Date:  2016-11-28

9.  Large vessel involvement by IgG4-related disease.

Authors:  Cory A Perugino; Zachary S Wallace; Nandini Meyersohn; George Oliveira; James R Stone; John H Stone
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

10.  Clinical features of IgG4-related periaortitis/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study.

Authors:  Makiko Ozawa; Yasunari Fujinaga; Junpei Asano; Akira Nakamura; Takayuki Watanabe; Tetsuya Ito; Takashi Muraki; Hideaki Hamano; Shigeyuki Kawa
Journal:  Arthritis Res Ther       Date:  2017-10-04       Impact factor: 5.156

View more
  8 in total

1.  Clinical and imaging findings suggestive of histopathological immunoglobulin G4-related disease: a single-center retrospective study.

Authors:  Byung-Woo Yoo; Sang-Won Lee; Jason Jungsik Song; Yong-Beom Park; Seung Min Jung
Journal:  Clin Rheumatol       Date:  2020-08-28       Impact factor: 2.980

2.  IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease.

Authors:  Linyi Peng; Panpan Zhang; Jieqiong Li; Zheng Liu; Hui Lu; Liang Zhu; Xiaorong Wang; Fei Teng; Xuemei Li; Huifang Guo; Yunyun Fei; Wen Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Arthritis Res Ther       Date:  2020-05-04       Impact factor: 5.156

3.  PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies.

Authors:  Yaelle Bavli; Bing-Mae Chen; Steve R Roffler; Marina A Dobrovolskaia; Eldad Elnekave; Shifra Ash; Yechezkel Barenholz; Keren Turjeman
Journal:  Molecules       Date:  2020-01-28       Impact factor: 4.411

4.  Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis.

Authors:  Kunkun Wang; Zhenfan Wang; Qiaozhu Zeng; Lijuan Zhu; Jingyuan Gao; Ziqiao Wang; Shanshan Zhang; Fei Yang; Danhua Shen; Yi Wang; Yanying Liu
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

5.  Retroperitoneal fibrosis, a rare entity with urorenal and vascular subtypes - preliminary data.

Authors:  Izabela Łoń; Jacek Lewandowski; Monika Wieliczko; Jolanta Małyszko
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

6.  Food-Specific IgG4 Antibody-Guided Exclusion Diet Improves Conditions of Patients with Chronic Pain.

Authors:  Ilenia Casini; Elena Fatighenti; Antonella Giannantoni; Lauretta Massai; Stefano Pieretti; Ilaria Ceccarelli; Anna Maria Aloisi
Journal:  Pain Ther       Date:  2022-05-25

7.  Clinical implications of elevated serum interleukin-6 in IgG4-related disease.

Authors:  Satoshi Tsukuda; Tsukasa Ikeura; Takashi Ito; Koh Nakamaru; Masataka Masuda; Yuichi Hori; Manami Ikemune; Masato Yanagawa; Toshihiro Tanaka; Takashi Tomiyama; Takashi Yamaguchi; Yugo Ando; Kazushige Uchida; Toshiro Fukui; Akiyoshi Nishio; Rika Terasawa; Noboru Tanigawa; Kazuichi Okazaki
Journal:  PLoS One       Date:  2020-01-17       Impact factor: 3.240

Review 8.  Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges.

Authors:  Ichiro Mizushima; Mitsuhiro Kawano
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-07-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.